Insider Transactions in Q3 2022 at Phreesia, Inc. (PHR)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 17
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
14
-0.25%
|
$378
$27.7 P/Share
|
Sep 16
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
35
-0.62%
|
$945
$27.7 P/Share
|
Sep 16
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,296
-1.18%
|
$34,992
$27.6 P/Share
|
Sep 15
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,290
-1.19%
|
$36,120
$28.58 P/Share
|
Sep 12
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-0.88%
|
$23,838
$29.19 P/Share
|
Sep 12
2022
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,854
+1.95%
|
-
|
Sep 12
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,036
-0.28%
|
$59,044
$29.19 P/Share
|
Sep 12
2022
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,178
+0.44%
|
-
|
Sep 12
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,160
-0.87%
|
$33,640
$29.19 P/Share
|
Sep 12
2022
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,178
+2.32%
|
-
|
Sep 12
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-0.28%
|
$18,154
$29.19 P/Share
|
Sep 12
2022
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,589
+0.7%
|
-
|
Sep 12
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,496
-0.28%
|
$101,384
$29.19 P/Share
|
Sep 12
2022
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+0.44%
|
-
|
Sep 12
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,359
-1.24%
|
$39,411
$29.19 P/Share
|
Sep 12
2022
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,649
+2.35%
|
-
|
Sep 12
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-1.22%
|
$39,237
$29.19 P/Share
|
Sep 12
2022
|
Michael J. Davidoff SVP, Payer Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,649
+2.33%
|
-
|
Aug 24
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,916
-6.06%
|
$159,068
$23.85 P/Share
|
Jul 29
2022
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+1.67%
|
$8,556
$23.49 P/Share
|
Jul 29
2022
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+1.61%
|
$8,556
$23.49 P/Share
|
Jul 29
2022
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+0.99%
|
$8,556
$23.49 P/Share
|
Jul 21
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,404
-1.28%
|
$35,100
$25.0 P/Share
|
Jul 14
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.92%
|
$26,818
$22.35 P/Share
|
Jul 14
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-0.3%
|
$47,080
$22.35 P/Share
|
Jul 14
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
624
-0.68%
|
$13,728
$22.35 P/Share
|
Jul 14
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-0.58%
|
$28,930
$22.35 P/Share
|
Jul 14
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,660
-0.29%
|
$80,520
$22.35 P/Share
|
Jul 14
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,128
-0.98%
|
$24,816
$22.35 P/Share
|
Jul 14
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-0.72%
|
$17,446
$22.35 P/Share
|
Jul 11
2022
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
2,605
-5.54%
|
$65,125
$25.57 P/Share
|
Jul 07
2022
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+17.86%
|
$0
$0.84 P/Share
|